RxDoctor Payments Data

Lindsay Worley, NP

Family · Richmond, INNPI 1497284186

Payments from drug & device makers

$1,728in general payments, 2019–2025

Across 103 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$442
  • C. R. Bard, Inc. & Subsidiaries$252
  • Rochester Medical Corporation$183
  • BD$177
  • 180 Medical, Inc.$159
  • Astellas Pharma US Inc$93
  • plus $423 from 10 others

What the payments were for

  • Food & beverage$1,728100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,728 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$119,794
Medicare patients
692
Services billed
3,217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron74$51,858
GemtesaVibegron31$34,980
Tamsulosin Hcl804$13,521
EliquisApixaban12$6,918
Finasteride410$4,925
Oxybutynin Chloride ErOxybutynin Chloride164$4,439
Potassium Citrate ErPotassium Citrate33$3,735
Solifenacin Succinate29$1,996
Testosterone Cypionate34$1,288
Trospium Chloride17$1,200
Trospium Chloride ErTrospium Chloride17$886
Silodosin11$478
Cephalexin54$424
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$326
Oxybutynin Chloride27$285

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$93$51,85874 claims
Sumitomo Pharma America, Inc.Gemtesa$442$34,98031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.

Other family in Richmond

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →